Fox Business - The Power to Prosper
Search Site

Allergan

Darden investors elect full Starboard slate

Christopher Davis of Kleinberg Kaplan and David Benoit of The Wall Street Journal discuss Starboards victory in replacing Darden’s board.

Read More

  1. What is behind the success of specialty pharma?

    Sanford Bernstein analyst Ronny Gal on the business model of specialty pharma.

  2. Allergan : Back off, Ackman

    Wall Street Journal reporter David Benoit and FOX Business contributor Bob Rice on Allergan looking to potential acquisitions to fend off activist investor Bill Ackman.

  3. Paulson acquiring 6M Allergan shares

    Liz Hoffman of the Wall Street Journal on hedge-fund manager John Paulson’s latest strategy.

  4. Valeant goes hostile

    FBN’s Liz MacDonald on Valeant’s hostile bid in its offer for Allergan .

  5. Trouble brewing at Valeant?

    FBN’s Liz MacDonald says Wall Street is talking about Valeant’s bad-balance sheet.

  6. Barra faces shareholders

    FBN’s Maria Bartiromo breaks down what you need to know.

  7. Corporate America gets hostile

    FBN’s Liz MacDonald on the reasons why hostile takeovers are increasing in the U.S.

  8. The key to stock-picking perfection

    M.D. Sass CEO Martin D. Sass gives insight into the markets.

  9. Valeant Pharmaceuticals sweetens offer for Allergan

    Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, Valeant boosting its bid for Allergan , GameStop’s mobile growth and Madison Square Garden shares getting a boost from the NY Rangers’ trip to the Stanley Cup finals.

  10. Allergan shares get boost from Valeant cash-stock offer

    FBN’s Nicole Petallides breaks down the day in the markets.

  11. Ackman calls for a vote

    FBN’s Liz MacDonald on Bill Ackman calling for a shareholder vote on the Valeant- Allergan merger.

  12. Is Ackman helping shareholders?

    Kleinberg Kaplan partner Chris Davis on Bill Ackman’s call for a shareholder vote on the Valeant- Allergan merger.

  1. Ackman threatens to sue Allergan over Salix deal

    David Benoit of The Wall Street Journal breaks down the latest on the fight to take over Allergan .

  2. Allergan in talks to buy Salix

    Wall Street Journal reporters David Benoit and Liz Hoffman on Allergan ’s efforts to buy Salix to ward off Valeant’s hostile bid.

  3. Shooter Jennings sings ‘She Thinks I Still Care’

    Musician Shooter Jennings sings ‘She Thinks I Still Care’ on Imus.

  4. The inversion play

    FBN’s Liz MacDonald on hedge funds’ inversion push.

  5. Allergan ’s top shareholder sells majority stake

    FBN’s Liz MacDonald on one of Allergan ’s largest shareholder selling its’ stake amid a takeover bid from Valeant.

  6. Allergan 2Q earnings beat expectations

    Earnings HQ: FBN’s Lori Rothman breaks down Allergan ’s second-quarter earnings report.

  7. What is behind the success of specialty pharma?

    Sanford Bernstein analyst Ronny Gal on the business model of specialty pharma.

‹ Prev12345Next ›
Freebase CC-BY
Source: Allergan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL